PolyNovo Limited (PNV.AX)
AUD 2.01
(-5.19%)
AUD 2.01
(-5.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -30.52 Million AUD | 0.9% |
| 2023 | -30.8 Million AUD | -729.63% |
| 2022 | 4.89 Million AUD | 111.93% |
| 2021 | 2.3 Million AUD | 242.86% |
| 2020 | -1.61 Million AUD | 88.39% |
| 2019 | -13.92 Million AUD | -342.34% |
| 2018 | -3.14 Million AUD | 42.75% |
| 2017 | -5.49 Million AUD | 48.85% |
| 2016 | -10.74 Million AUD | -210.56% |
| 2015 | -3.46 Million AUD | 25.84% |
| 2014 | -4.66 Million AUD | -67.63% |
| 2013 | -2.78 Million AUD | 7.46% |
| 2012 | -3 Million AUD | 12.97% |
| 2011 | -3.45 Million AUD | 42.23% |
| 2010 | -5.98 Million AUD | 51.1% |
| 2009 | -12.23 Million AUD | 25.72% |
| 2008 | -16.47 Million AUD | 20.0% |
| 2007 | -20.59 Million AUD | 11.68% |
| 2006 | -23.31 Million AUD | -36.44% |
| 2005 | -17.08 Million AUD | 1.55% |
| 2004 | -17.35 Million AUD | -153.43% |
| 2003 | -6.84 Million AUD | 43.27% |
| 2002 | -12.07 Million AUD | -114.8% |
| 2001 | -5.62 Million AUD | -182340.77% |
| 2000 | -3081.00 AUD | 99.94% |
| 1999 | -5.42 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -30.52 Million AUD | 0.9% |
| 2024 Q4 | -30.52 Million AUD | 0.0% |
| 2024 Q2 | -30.24 Million AUD | 0.0% |
| 2023 FY | -30.8 Million AUD | -729.63% |
| 2023 Q2 | -32.59 Million AUD | 0.0% |
| 2023 Q4 | -30.8 Million AUD | 0.0% |
| 2022 Q2 | 7.59 Million AUD | 0.0% |
| 2022 Q4 | 4.89 Million AUD | 0.0% |
| 2022 FY | 4.89 Million AUD | 111.93% |
| 2021 Q4 | 2.3 Million AUD | 0.0% |
| 2021 Q2 | 2.34 Million AUD | 0.0% |
| 2021 FY | 2.3 Million AUD | 242.86% |
| 2020 Q2 | -5.72 Million AUD | 0.0% |
| 2020 FY | -1.61 Million AUD | 88.39% |
| 2020 Q4 | -1.61 Million AUD | 0.0% |
| 2019 Q4 | -13.92 Million AUD | 0.0% |
| 2019 Q2 | -20.81 Million AUD | 0.0% |
| 2019 FY | -13.92 Million AUD | -342.34% |
| 2018 Q4 | -3.14 Million AUD | 0.0% |
| 2018 FY | -3.14 Million AUD | 42.75% |
| 2018 Q2 | -25.7 Million AUD | 0.0% |
| 2017 FY | -5.49 Million AUD | 48.85% |
| 2017 Q2 | -9.78 Million AUD | 0.0% |
| 2017 Q4 | -5.49 Million AUD | 0.0% |
| 2016 FY | -10.74 Million AUD | -210.56% |
| 2016 Q2 | -13.4 Million AUD | 0.0% |
| 2016 Q4 | -10.74 Million AUD | 0.0% |
| 2015 Q2 | -804 Thousand AUD | 0.0% |
| 2015 Q4 | -3.46 Million AUD | 0.0% |
| 2015 FY | -3.46 Million AUD | 25.84% |
| 2014 Q2 | -258.43 Thousand AUD | 0.0% |
| 2014 FY | -4.66 Million AUD | -67.63% |
| 2014 Q4 | -4.66 Million AUD | 0.0% |
| 2013 FY | -2.78 Million AUD | 7.46% |
| 2013 Q2 | -186 Thousand AUD | 0.0% |
| 2013 Q4 | -2.78 Million AUD | 0.0% |
| 2013 Q3 | -2.78 Million AUD | -1396.55% |
| 2013 Q1 | -186 Thousand AUD | 93.82% |
| 2012 Q4 | -3 Million AUD | 0.0% |
| 2012 FY | -3 Million AUD | 12.97% |
| 2011 Q4 | -3.45 Million AUD | 0.0% |
| 2011 FY | -3.45 Million AUD | 42.23% |
| 2010 Q4 | -5.98 Million AUD | 0.0% |
| 2010 FY | -5.98 Million AUD | 51.1% |
| 2009 Q4 | -12.23 Million AUD | 0.0% |
| 2009 FY | -12.23 Million AUD | 25.72% |
| 2008 Q4 | -16.47 Million AUD | 0.0% |
| 2008 FY | -16.47 Million AUD | 20.0% |
| 2007 Q4 | -20.59 Million AUD | 0.0% |
| 2007 FY | -20.59 Million AUD | 11.68% |
| 2006 FY | -23.31 Million AUD | -36.44% |
| 2006 Q4 | -23.31 Million AUD | 0.0% |
| 2005 Q4 | -17.08 Million AUD | 0.0% |
| 2005 FY | -17.08 Million AUD | 1.55% |
| 2004 Q4 | -17.35 Million AUD | 0.0% |
| 2004 FY | -17.35 Million AUD | -153.43% |
| 2003 FY | -6.84 Million AUD | 43.27% |
| 2003 Q4 | -6.86 Million AUD | 0.0% |
| 2002 FY | -12.07 Million AUD | -114.8% |
| 2002 Q4 | -12.08 Million AUD | 0.0% |
| 2001 FY | -5.62 Million AUD | -182340.77% |
| 2001 Q4 | -5.62 Million AUD | 0.0% |
| 2000 FY | -3081.00 AUD | 99.94% |
| 2000 Q4 | -3081.00 AUD | 0.0% |
| 1999 FY | -5.42 Million AUD | 0.0% |
| 1999 Q4 | -5.42 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | -19.782% |
| Adherium Limited | -6.1 Million AUD | -400.087% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -714.673% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -747.191% |
| Anteris Technologies Ltd | -28.49 Million AUD | -7.116% |
| Control Bionics Limited | -19.02 Thousand AUD | -160382.599% |
| CardieX Limited | 2.74 Million AUD | 1211.559% |
| Compumedics Limited | 5.08 Million AUD | 700.098% |
| Cochlear Limited | -269.9 Million AUD | 88.69% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 4469.79% |
| Cyclopharm Limited | -7.49 Million AUD | -307.074% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | -94.424% |
| Nova Eye Medical Limited | -2.8 Million AUD | -989.472% |
| HeraMED Limited | -799.34 Thousand AUD | -3718.987% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 310.78% |
| ImpediMed Limited | -23.48 Million AUD | -29.963% |
| InhaleRx Limited | -155.54 Thousand AUD | -19525.958% |
| LBT Innovations Limited | -604 Thousand AUD | -4954.139% |
| Micro-X Limited | 826.99 Thousand AUD | 3791.298% |
| Neurotech International Limited | -2.11 Million AUD | -1346.448% |
| OncoSil Medical Limited | -4.43 Million AUD | -588.984% |
| Respiri Limited | 413.68 Thousand AUD | 7479.215% |
| SomnoMed Limited | -15.16 Million AUD | -101.328% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -475.553% |
| Uscom Limited | -1.53 Million AUD | -1894.404% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -647.67% |